Compare CEPU & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CEPU | ATEC |
|---|---|---|
| Founded | 1989 | 1990 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 2017 | 2006 |
| Metric | CEPU | ATEC |
|---|---|---|
| Price | $15.75 | $12.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | $17.50 | ★ $22.00 |
| AVG Volume (30 Days) | 281.9K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $27.76 | $17.79 |
| Revenue Next Year | $28.12 | $16.43 |
| P/E Ratio | $12.24 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.43 | $8.82 |
| 52 Week High | $18.50 | $23.29 |
| Indicator | CEPU | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 39.15 |
| Support Level | $15.67 | $11.99 |
| Resistance Level | $16.60 | $12.97 |
| Average True Range (ATR) | 0.64 | 0.67 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 68.41 | 32.51 |
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.